Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus.

MLA

Heise, Tim, et al. “Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus.” Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders, vol. 5, no. 1, June 2014, pp. 255–65. EBSCOhost, https://doi.org/10.1007/s13300-014-0070-2.

APA

Heise, T., Nosek, L., Roepstorff, C., Chenji, S., Klein, O., & Haahr, H. (2014). Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders, 5(1), 255–265. https://doi.org/10.1007/s13300-014-0070-2

Chicago

Heise, Tim, Leszek Nosek, Carsten Roepstorff, Suresh Chenji, Oliver Klein, and Hanne Haahr. 2014. “Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus.” Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders 5 (1): 255–65. doi:10.1007/s13300-014-0070-2.